Recognition and clearance of methoxypoly(ethyleneglycol)2000-grafted liposomes by macrophages with enhanced phagocytic capacity - Implications in experimental and clinical oncology

被引:23
作者
Laverman, P
Carstens, MG
Storm, G
Moghimi, SM [1 ]
机构
[1] Univ Brighton, Sch Pharm & Biomol Sci, Mol Targeting & Polymer Toxicol Grp, Brighton BN2 4GJ, E Sussex, England
[2] Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands
[3] Univ Utrecht, Inst Pharmaceut Sci, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2001年 / 1526卷 / 03期
关键词
long circulating liposome; Kupffer cell; macrophage stimulation; poloxamine; cancer drug delivery;
D O I
10.1016/S0304-4165(01)00142-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intravenous injection of an endotoxin-free solution of poloxamine-908 to rats can enhance the phagocytic clearance capacity of tissue macrophages, particularly those of the liver and the spleen. Such stimulated cells were able to clear a significant portion of intravenously injected methoxypoly(ethyleneglycol)2000 liposomes (mean size of 87 nm), labelled with technetium-99m via the N-hydroxysuccinimidyl hydrazine nicotinate hydrochloride derivative of distearoyl phosphatidylethanolamine, within 4 h post administration. These liposomes, otherwise, exhibit long circulatory behaviour in control animals, with poor localization to the liver and spleen. We suggest that such technetium-99m-labelled engineered vesicles may be of aid for detection of the liver and spleen macrophages with enhanced phagocytic clearance capacity by gamma scintigraphy. Alterations in the phagocytic activity of liver and spleen macrophages is known to occur during cancer. Therefore, such diagnostic procedures may prove useful for patient selection or for monitoring the progress of treatment with long circulating nanoparticles carrying anti-cancer agents, thus minimizing damage to this important line of body's defence cells, and are discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:227 / 229
页数:3
相关论文
共 12 条
[1]  
ADAMS DO, 1992, MACROPHAGE, P75
[2]   LIPOSOMAL DOXORUBICIN-INDUCED TOXICITY - DEPLETION AND IMPAIRMENT OF PHAGOCYTIC-ACTIVITY OF LIVER MACROPHAGES [J].
DAEMEN, T ;
HOFSTEDE, G ;
KATE, MTT ;
BAKKERWOUDENBERG, IAJM ;
SCHERPHOF, GL .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (05) :716-721
[3]   Toxicity of doxorubicin entrapped within long-circulating liposomes [J].
Daemen, T ;
Regts, J ;
Meesters, M ;
TenKate, MT ;
BakkerWoudenberg, IAJM ;
Scherphof, GL .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (01) :1-9
[4]  
Dams ETM, 2000, J PHARMACOL EXP THER, V292, P1071
[5]  
Drummond DC, 1999, PHARMACOL REV, V51, P691
[6]  
ELLENS H, 1983, CANCER RES, V43, P2927
[7]  
Laverman P, 1999, J NUCL MED, V40, P192
[8]   A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats [J].
Moghimi, SM ;
Gray, T .
CLINICAL SCIENCE, 1997, 93 (04) :371-379
[9]   ENHANCED HEPATIC-CLEARANCE OF INTRAVENOUSLY ADMINISTERED STERICALLY STABILIZED MICROSPHERES IN ZYMOSAN-STIMULATED RATS [J].
MOGHIMI, SM ;
HEDEMAN, H ;
CHRISTY, NM ;
ILLUM, L ;
DAVIS, SS .
JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 54 (06) :513-517
[10]   Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats [J].
Moghimi, SM ;
Patel, HM .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1996, 1285 (01) :56-64